{"id":"NCT05288348","sponsor":"Frank Guyette","briefTitle":"DSUVIA Early Evaluation of Pain Trial","officialTitle":"DSUVIA Early Evaluation of PAIN (DEEP) Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-08-05","primaryCompletion":"2024-01-21","completion":"2024-01-21","firstPosted":"2022-03-21","resultsPosted":"2025-04-30","lastUpdate":"2025-04-30"},"enrollment":150,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Traumatic Injury"],"interventions":[{"type":"DRUG","name":"Sufentanil 30 MCG Sublingual Tablet","otherNames":[]},{"type":"DRUG","name":"standard care pain treatment","otherNames":[]}],"arms":[{"label":"DSUVIA (sufentanil)","type":"EXPERIMENTAL"},{"label":"Standard Care","type":"ACTIVE_COMPARATOR"}],"summary":"Randomized, interventional trial of Emergency Department (ED) administration of DSUVIA (sufentanil) versus standard care pain management comparing pain treatment outcomes in injured patients with moderate to severe pain","primaryOutcome":{"measure":"Verbally Administered Numeric Rating Scale (VNRS)","timeFrame":"30 minutes after administration","effectByArm":[{"arm":"DSUVIA (Sufentanil)","deltaMin":68,"sd":27},{"arm":"Standard Care","deltaMin":66,"sd":23}],"pValues":[{"comp":"OG000 vs OG001","p":"0.56"},{"comp":"OG000 vs OG001","p":"0.92"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["39919020"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":76},"commonTop":["Nausea","Headache","Vomiting","Dizziness","Hypoxia"]}}